C3 glomerulonephritis in multiple myeloma: A case report and literature review

Guang Yin1, Zhen Cheng, Cai-Hong Zeng

  • 1National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.

Medicine
|September 16, 2016
PubMed

Insights

C3 glomerulonephritis (C3 GN), a kidney disease from complement system activation, is linked to multiple myeloma (MM). This case study suggests C3 GN may be a new kidney complication in MM patients.

Area of Science:

  • Nephrology
  • Complement System Biology
  • Hematology

Background:

  • C3 glomerulonephritis (C3 GN) is characterized by C3 deposition in the kidneys due to alternative complement pathway dysregulation.
  • While linked to systemic diseases, its association with multiple myeloma (MM) is not well-established.

Observation:

  • A 64-year-old female presented with hematuria, renal dysfunction, anemia, and weight loss.
  • Diagnosis of IgG-λ multiple myeloma was confirmed via serum immunofixation and bone marrow biopsy.
  • Renal biopsy revealed histological features of C3 GN, including mesangial/endocapillary proliferation and C3 deposition.

Findings:

  • Histopathology confirmed C3 GN with characteristic glomerular C3 deposition and low serum C3 levels.
  • The findings suggest C3 GN occurring in the context of multiple myeloma.
  • This case provides evidence for a link between C3 GN and MM.

Implications:

  • C3 GN may represent a novel nephropathy associated with multiple myeloma.
  • Further research is needed to elucidate the underlying mechanisms of this association.
  • This highlights the importance of renal evaluation in MM patients presenting with kidney abnormalities.
Abstract

Related Concept Videos